Insider Transactions in Q1 2024 at Outset Medical, Inc. (OM)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 15
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
2,391
-0.98%
|
$4,782
$2.13 P/Share
|
Mar 12
2024
|
Brent D. Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
108,024
+50.0%
|
-
|
Mar 01
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,584
-0.49%
|
$4,752
$3.15 P/Share
|
Feb 29
2024
|
Nabeel Ahmed Chief Financial Officer |
BUY
Other acquisition or disposition
|
Direct |
1,584
+0.49%
|
$3,168
$2.68 P/Share
|
Feb 23
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,639
-3.19%
|
$31,917
$3.72 P/Share
|
Feb 23
2024
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,922
+5.9%
|
-
|
Feb 23
2024
|
Leslie Trigg Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
45,538
-4.72%
|
$136,614
$3.72 P/Share
|
Feb 23
2024
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
131,687
+12.01%
|
-
|
Feb 15
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,320
-0.63%
|
$15,960
$3.57 P/Share
|
Feb 15
2024
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,500
-0.77%
|
$7,500
$3.57 P/Share
|
Feb 15
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
3,341
-1.35%
|
$10,023
$3.57 P/Share
|
Feb 15
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
617
-0.25%
|
$1,851
$3.57 P/Share
|
Feb 15
2024
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,866
-0.68%
|
$5,598
$3.57 P/Share
|
Feb 15
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,403
-1.39%
|
$13,209
$3.57 P/Share
|
Jan 16
2024
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
996
-0.31%
|
$3,984
$4.29 P/Share
|
Jan 16
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,480
-0.59%
|
$5,920
$4.29 P/Share
|
Jan 16
2024
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
678
-0.28%
|
$290,862
$429.0 P/Share
|
Jan 16
2024
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
768
-1.23%
|
$3,072
$4.29 P/Share
|
Jan 16
2024
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
723
-0.26%
|
$2,892
$4.29 P/Share
|
Jan 16
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
8,126
-0.96%
|
$32,504
$4.29 P/Share
|
Jan 16
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,726
-0.54%
|
$6,904
$4.29 P/Share
|
Jan 12
2024
|
Steven S. Williamson Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
217,904
+19.89%
|
-
|
Jan 12
2024
|
John L. Brottem General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
201,060
+23.62%
|
-
|
Jan 12
2024
|
Marc Nash SVP Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
199,162
+23.68%
|
-
|
Jan 12
2024
|
Stacey L. Porter Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,586
+5.45%
|
-
|
Jan 12
2024
|
Jean Olivier Racine Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,638
+21.61%
|
-
|
Jan 12
2024
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
457,438
+17.04%
|
-
|
Jan 12
2024
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
241,904
+21.68%
|
-
|
Jan 08
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
14,188
-3.52%
|
$70,940
$5.49 P/Share
|
Jan 08
2024
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,055
-6.24%
|
$35,275
$5.49 P/Share
|
Jan 08
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,709
-12.23%
|
$53,545
$5.49 P/Share
|
Jan 08
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
7,344
-13.08%
|
$36,720
$5.49 P/Share
|
Jan 08
2024
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
4,766
-7.52%
|
$23,830
$5.49 P/Share
|
Jan 08
2024
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,905
-5.03%
|
$19,525
$5.49 P/Share
|